This article was originally published in The Tan Sheet
Fourth quarter 7% rise in revenue to $102.6 mil. partially due to success of ePharmanex Internet initiative in Japan that allows distributors to create personalized Web sites, parent company Nu Skin Enterprises reports Feb. 13. Nu Skin says Web site product generates revenue from initial sale and is designed to increase number of executive-level distributors. Pharmanex' FY 2000 revenue rose a slight 1% to $387.6 mil. Supplement manufacturer's BioGinkgo 27/7 product recently was awarded U.S. patent covering preparation methods and product composition
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC